InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.95
(
0.24%
)
US TECH 100
19,121.20
(
-0.45%
)
Dow Jones
39,503.56
(
0.90%
)
Brent Oil
85.17
(
1.37%
)
Bitcoin
60,902.12
(
-3.57%
)
Post# of 252317
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Summer2762

Send PM Follow Ignore
Followers 7
Posts 193
Boards Moderated 0
Alias Born 10/26/2011

Summer2762

Re: pcrutch post# 138474

Friday, 03/09/2012 10:59:03 AM

Friday, March 09, 2012 10:59:03 AM

Post# of 252317

I have a hard time believing the trial wouldnt have hit the OS endpoint if given a little more maturity.



This abi trial had a higher (practical) hurdle than the usual. In practice (not per protocol), not only the trial had to show good OS benefit by reaching statistical significance, the OS benefit had to be better than abi's post-chemo benefit.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up